PV-0552: Urethra-sparing SBRT for prostate cancer: acute toxicity results from a randomized phase II trial. (May 2017) - Zilli, T.; Jorcano, S.; Bral, S.; Rubio, C.; Bruynzeel, A.; Oliveira, A.; Abacioglu, U.; Minn, H.; Symon, Z.; Miralbell, R.